Telemedicine Kickbacks: What the Consult Fee Really Buys

Telemedicine kickbacks pay for referrals, prescriptions or signed orders that generate government healthcare claims. The invoice may call the payment a consultation fee, a review fee or compensation for supervision. Inside the business, the revealing detail is what happens when the clinician says no. Does the price fall? Does the file go to another doctor? Does the company get paid only after a pharmacy collects? Those decisions show what the buyer wanted from the encounter.

What Does Kickback Mean in Healthcare?

A kickback in healthcare is money or another benefit paid to buy a referral or an order that Medicare or another federal health care program will cover. The benefit can be access to patients whose visits the practitioner can bill. Cash changes hands in some arrangements. In others, the business opportunity is the payment.

The remote visit can be free because someone farther along the chain pays for its output. A pharmacy wants a prescription, a laboratory wants a test order, and an equipment supplier wants a signed medical-necessity order. The supplier’s Medicare claim can start with a practitioner who never bills Medicare for a visit.

When a Consult Fee Is Really an Approval Price

When a telemedicine consult price drops because a doctor rejects a prescription, the company has put a price on the decision. In a criminal information concerning Health Pain Solutions and RediDoc, the government alleged that Health Pain Solutions was charged $95 for a successful purported consultation and sought the $15 rejection price when an order was rejected.

These were charges from the telemedicine platform to the marketer. Approval made the transaction more valuable to the business buying the consultation.

The same criminal information alleged that a telehealth hourly contract promised a percentage of insurance reimbursement: 50% of collected shipped claims. The information described the payment as a share of collections after medication costs. The clock and the reimbursement ledger tell different stories.

For a whistleblower who sees someone paid per approved telehealth order, the contract and the approval history belong together. We examine what a rejection did to the invoice, who received the payment and what the resulting prescription represented. A fee schedule can expose the incentive that the contract’s title leaves out.

What Are Some Examples of Kickbacks in Healthcare?

Telemedicine cases show payments for signed orders, bundles of orders for a beneficiary and purported supervision. Each buys a different part of the path to reimbursement.

A Beneficiary Price Can Buy Several Orders

The Justice Department’s account of a criminal case involving the owner of two telemedicine companies describes orders sold to marketers for approximately $90 per Medicare beneficiary. The marketers resold them to brace suppliers and pharmacies, which submitted claims for unnecessary products.

The owner, a nurse practitioner who pleaded guilty, also signed prescriptions herself. Practitioners working for her signed orders for four or more orthotics for over 3,000 beneficiaries. The patient was the pricing unit, while multiple products could follow from that patient’s orders. A payment ledger organized by beneficiary can therefore conceal how much equipment the order stream produces.

A Supervision Fee Can Buy a Credential

A criminal information describing a genetic-testing network alleged payments of approximately $20 per test order and $2 per purported supervision. It alleged that consulting language concealed payment per prescription regardless of whether a consultation occurred.

A telemedicine supervision fee with no actual supervision puts the claimed work at the center of the inquiry. The practitioner signing an order and the professional supplying supervisory credentials occupy different positions. We connect the payment to the work each person was supposed to perform, the named supervisor and the patient records showing what actually happened.

The Staffing Invoice Followed the Approved Order

Telemedicine staffing agency kickbacks can put the approval price in the staffing customer’s invoice. The Jackson & Coker LocumTenens settlement agreement describes a $45 daily administrative fee charged to Nationwide Health Advocates and $35 for an approved order. These were contractual charges to the customer. The staffing company did not itself bill Medicare; suppliers and laboratories billed on the resulting orders.

That is a different payment from the clinician’s compensation for reviewing a file. We compare the staffing contract with invoices and actual payments, then connect the approved order to the claim it supported.

The rule governing how personal-services contracts set pay changed on January 19, 2021, during Jackson & Coker’s covered period of August 2020 through September 2021. We examine the contract and the work against the rules for the period involved. The invoice’s approval trigger and the work actually performed remain central to that review.

When the Review Fee Survives Rejection

A review fee paid even when testing is rejected shifts attention to the review and the signed certification. In a Fourth Circuit opinion in a criminal case involving a telemedicine practitioner, the court described compensation of $12 to $15 per review whether or not the practitioner approved testing.

The court examined the practitioner’s certifications about the patient relationship and planned use of results behind Medicare-paid tests. For an insider comparing clinician pay, the review fee and the work represented by the signature belong together.

Who Pays Whom in a Telemedicine Order Chain?

A pharmacy can pay a marketer who pays a telemedicine company, which supplies practitioners and orders. A supplier or laboratory can finance a similar chain. The Office of Inspector General’s July 20, 2022 Special Fraud Alert describes call centers, brokers, staffing companies, marketers and purported telemedicine companies assembling orders for businesses that bill federal programs.

The brand on the patient’s screen may sit apart from the professional practice, the company paying the clinician and the business submitting the claim. A management company can handle staffing, billing and collections. A platform can hold the intake, communication and order-routing records. The contracts and payment counterparties identify which business controls each step. The laboratory-side allegations against Access DX concern payments for false telemedicine orders. The equipment-supplier cases include Metro DME Supply and Ortho Pain Solutions. At the signature step, a criminal information about Real Time Physicians, the government alleged that practitioners received forms already prepared for signature.

Pharmacy Money Can Pay the Marketer and the Doctor

When a pharmacy pays a marketer who pays a telehealth doctor, its money can finance the prescription it receives. The government’s allegations concerning Patient Care America described marketers generating prescriptions for compounded pain creams, scar creams and vitamins reimbursed by TRICARE. The government alleged that marketers paid telemedicine doctors who prescribed without seeing patients and sometimes without speaking to them.

The alleged arrangement also covered patient copays through a sham charity. Complaints from patients raised questions about consent and the prescriber relationship. The money bought more than access to a doctor: it helped get the prescription generated and the product accepted.

Management Approval and the Investor’s Financing

The Patient Care America allegations reached its private-equity investor, Riordan, Lewis & Haden, through knowledge, agreement and financing of the prescription arrangement.

That makes documented participation the question behind telemedicine investor kickback liability. Ownership identifies an interest in the business; communications and payment decisions can show what the investor knew and authorized. Who received the patient complaints? Did they reach the people approving financing or paying marketers? We connect those decisions to the prescriptions and claims they supported.

Patient Membership Fees Can Hide Supplier Payments

When telehealth patient membership fees are really supplier payments, the books hide who bought the order. In a guilty plea involving the Video Doctor and AffordADoc network, an owner admitted concealing payments from order purchasers behind a patient-membership revenue story. He admitted receiving kickbacks, paying clinicians for unnecessary orders and concealing funds in nominee accounts.

That makes the membership explanation something to compare with the actual payer. A subscription, an encounter, a product shipment and a clinician’s payment are separate business events. The ledger can show whether money described as coming from patients actually arrived from businesses buying their orders.

The criminal case involving orders sold by beneficiary also shows how a telemedicine company can conceal the money through shell accounts and nominee owners. The Justice Department described a nominee opening an account in the company’s name. The account holder’s name and the person controlling the order business can lead to different places.

Access to Billable Patients Can Be the Benefit

In a criminal information concerning Panda Conservation Group, the government alleged that a practitioner received beneficiary referrals and the opportunity to bill Medicare for telemedicine visits as the inducement connected to genetic-test orders.

The allegation puts access to patients on the payment side of the transaction. A practitioner could gain visit revenue while the laboratory billed for the testing. We examine the referral stream and the opportunity to bill alongside any cash transfers.

Is It Illegal for Doctors to Get Kickbacks?

Yes. The Anti-Kickback Statute prohibits knowingly and willfully paying or receiving benefits to induce or reward covered referrals and orders.

The Inspector General’s alert identifies concrete features worth examining together: recruitment around free or low-cost products, inadequate patient contact, pay tied to order volume, a restricted product menu and missing follow-up. It also flags federal-beneficiary-only businesses and businesses claiming to exclude federal patients while generating federal claims.

What Evidence Is Needed to Prove Fraud?

The useful evidence connects the payment, the order or referral it was intended to produce, and the claim that followed. Connecting them is the work we do with you.

A claim for items or services resulting from a kickback violation can be a false claim under the False Claims Act. A 2024 analysis in Rutgers University Law Review, Plausible Cause: Connecting the FCA and AKS in the Context of Health Care Fraud, identifies a recurring proof problem: connecting the kickback arrangement to the particular claims it produced. For a telemedicine insider, that connection can run through the beneficiary, signed order, receiving supplier and reimbursement record.

Call-center recordings can help explain what the order buyer received. A whistleblower complaint concerning Empire Pain alleged that suppliers paid for completed patient leads.

We work with practitioners, marketers, billing staff and other insiders whose records connect these decisions. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The starting point is what you know about the payment and the order it purchased.

You Know What Triggered the Payment

If you know why an approved order earned more, who funded the patient leads or what a supervision fee actually bought, speak to one of our whistleblower experts about that arrangement. We build the case with you around the money, the clinical representations and the resulting claims, and bring in telehealth fraud whistleblower lawyers who understand referral-payment schemes. We stay beside you as your partner through the case.